Shanghai Bao Pharmaceuticals Co., Ltd. (2659)
Market Closed
12 Aug, 08:00
HKEX HKEX Primary 17. 10
HKD +0.15
+0.885%
7.13B Market Cap
- P/E Ratio
- Div Yield
281,400 Volume
- Eps
16.95 HKD
Previous Close Want to track 2659 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shanghai Bao Pharmaceuticals Co., Ltd. (2659) Statistics
Valuation metrics
Market Cap 7.13B
Enterprise value 7.19B
Trailing P/E (ttm) -16.18
Forward P/E -
PEG ratio -
Price/Sales (ttm) 145.1
Price/Book (mrq) 3.87
Enterprise Value/Revenue 126.22
Enterprise Value/EBITDA -22.59
Overview
Shares outstanding 325.98M
Float 74.89M
Shares short -
% Held by insiders 0.59%
% Held by institutions 0.17%
Average volume (10 days) 3.93M
Average volume (90 days) 5.68M
Price summary
52-Week low 15.67
52-Week high 206
Beta -
50-Day moving average 64.73
200-Day moving average 90.47
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.89%
Operating margin -26.92%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.31%
Income Statement
Revenue (ttm) 56.93M
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) 0.54%
Gross profit (ttm) 50.67M
EBITDA -318.09M
Net income to common (ttm) -457.85M
Diluted EPS (ttm) -1.58
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.44B
Total cash per share (mrq) 3.81
Total debt (mrq) 364.83M
Total Debt/Equity (mrq) 19.79
Current ratio (mrq) 4.12%
Book value per share (mrq) 5.66
Cash Flow
Cash flow statement -208.54M
Levered free cash flow (LFCF) -123M
